FDC Quarterly Results for Trading Insights
FDC • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹28 Cr
QSept 2025
FDC Quarterly Results Key Highlights
- Revenue of ₹494 Cr in Sept 2025 (-2.8% vs Mar 2025, -10.0% vs Sept 2024)
- Net Profit of ₹28 Cr in Sept 2025 (-28.2% vs Mar 2025, -61.1% vs Sept 2024)
- EBITDA of ₹54 Cr in Sept 2025 (-22.9% vs Mar 2025)
- Operating Margin of 7.0% in Sept 2025 (-4.0pp vs Mar 2025)
- Earnings Per Share of ₹1.75 in Sept 2025 (-26.5% vs Mar 2025)
FDC Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 494 | 508 | 684 | 549 | 482 | -2.8% | -10.0% |
| Net Profit (₹ Cr) | 28 | 39 | 121 | 72 | 46 | - | - |
| EBITDA (₹ Cr) | 54 | 70 | 176 | 105 | 77 | - | - |
| EPS (₹) | 1.75 | 2.38 | 7.45 | 4.43 | 2.84 | - | - |
| Operating Margin (%) | 7.0% | 11.0% | 22.0% | 14.0% | 12.0% | - | - |
FDC Share Price Trend Around Quarterly Results
Visualize FDC's 1-year price movement across quarterly results — ideal for logging trades in FDC share price
chart using Tickjournal. All values in ₹.
Related Pages for FDC
Additional stock information and data for FDC
Revenue Trend (₹ Cr)
Sept 2024
549
Jun 2025
684
Mar 2025
508
Sept 2025
494
Net Profit Trend (₹ Cr)
Sept 2024
72
Jun 2025
121
Mar 2025
39
Sept 2025
28
Operating Margin Trend (%)
Sept 2024
14.0%
Jun 2025
22.0%
Mar 2025
11.0%
Sept 2025
7.0%
Sector Competitors - Quarterly Performance Comparison
Comparing FDC quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹422,330.94 Cr | 1760.2 | 14,875 | 3,125 | +10.8% | - | 21.0% | 135.4 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6642.5 | 2,860 | 689 | +7.1% | - | 24.1% | 255.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3936.8 | 3,219 | 591 | +11.3% | - | 18.4% | 224.4 |
|
Cipla
Sept 2025 |
₹121,238.47 Cr | 1530.8 | 7,716 | 1,353 | +12.0% | - | 17.5% | 91.5 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,829.57 Cr | 1256.2 | 9,135 | 1,337 | +1.1% | - | 14.6% | 77.6 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores